DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study aims to compare the mid- and long-term outcomes between paclitaxel-coated balloon and primary selective stenting in the treatment of TASC C/D femoropopliteal artery occlusive disease.
Epistemonikos ID: 6ef81849db4f03fffa9662b4d5cb91ad9b328812
First added on: May 13, 2024